Purpose: To describe histopathologic features of an eye with retinal angiomatous proliferation (RAP) secondary to age-related macular degeneration treated with serial ranibizumab injections and to correlate these findings with spectral domain optical coherence tomography.
R
etinal angiomatous proliferation (RAP) is a form of intraretinal neovascularization in patients with agerelated macular degeneration that is distinct from the occult and classic choroidal neovascularization seen in age-related macular degeneration. [1] [2] [3] [4] In RAP lesions, there is active proliferation of telangiectatic neovascular vessels within the retina. Formation of retinal-choroidal anastomoses is seen, but thought to be a late feature.
There have been numerous descriptions of the tomographic features of RAP lesions using spectral domain optical coherence tomography. [5] [6] [7] [8] [9] [10] [11] [12] These studies have described the intraretinal neovascularization of RAP as a highly reflective lesion in the neurosensory retina. A consistent tomographic feature in eyes with RAP has been the absence of retinal pigment epithelium beneath the RAP lesion. To date, no histopathologic study has been conducted to confirm the tomographic appearance of RAP lesions.
Here, we present the histopathology of a case in which an RAP lesion was identified in a postmortem eye that had been imaged with spectral domain optical coherence tomography 7 weeks before the patient's death. We provide histopathologic evidence supporting the presumed OCT appearance of RAP lesions. In addition, we describe the first histopathologic examination of an RAP lesion treated with serial ranibizumab.
Case Report
A 93-year-old man with longstanding age-related macular degeneration presented for routine evaluation for ranibizumab intravitreal injection. He had previously received treatment for RAP in the left eye with intravitreal triamcinolone on 3 occasions followed by 25 serial injections of ranibizumab over a period of 50 months (November 2006 through June 2011). His ocular history was also significant for pseudophakia and primary open angle glaucoma in both eyes. At the time of the examination, the patient's visual acuity measured 20/400 in the right eye because of a longstanding disciform macular scar. The visual acuity measured 20/40 in the left eye in which an RAP lesion had been previously identified by fluorescein angiography (Figure 1 ). The left eye was examined with spectral domain optical coherence tomography and found to have a small amount of residual fluid and was treated with an additional ranibizumab injection. The patient died 7 weeks after, subsequent to a hip fracture.
Methods
The patient was evaluated at a tertiary care referral center where he underwent clinical evaluation that included a complete eye examination and spectral domain optical coherence tomography (Spectralis Heidelberg Engineering Inc, Heidelberg, Germany) on the date of his last examination. His most recent color fundus photographs and fluorescein angiography were performed 6 years before this last evaluation ( Figure 1 ). The eyes were obtained postmortem and were fixed in 10% neutral-buffered formalin. They were then dehydrated in ethanol, cleared in xylene, and embedded in paraffin. Serial 5-micrometer sections were prepared from the left globe in a plane parallel to the pupil, the optic nerve, and the macula. Sections were then stained with hematoxylin and eosin and evaluated with light microscopy.
Results
The histopathologic features of a section through the central retina at a location 370 microns superior to the fovea are illustrated in Figure 2A . There is a vascular complex located in the outer retina abutting the There is generalized loss of the photoreceptor outer segments, outer nuclear layer, and some of the outer plexiform layer. The retinal pigment epithelium monolayer is disrupted underlying the RAP lesion; however, the inner portion of Bruch membrane is intact, and there is a continuous layer of basophilic basal laminar deposit present. There is artifactitious separation of the inner portion of Bruch membrane and the basal laminar deposits from the underlying elastic portion of Bruch membrane. There is a thin band of fibrous tissue within the pigment epithelial detachment. It is likely that this tissue represents regressed Type 1 choroidal neovascularization, although no vascular elements could be identified. A section through another area of the RAP lesion located 30 microns inferior to the first area ( Figure 2B ) shows that the RAP lesion has branched. There are only sparse cells present within the structure of the complex. Moving further inferiorly to an area 250 microns superior to the fovea ( Figure 2C ), the RAP lesion is located more superficially in the retina, now abutting the inner nuclear layer. As the lesion terminates, 200 microns superior to the fovea, it is located in the inner plexiform layer ( Figure 2D ). Examination of each 5 micron section failed to reveal a definite anastomosis with a retinal vessel.
Spectral domain optical coherence tomography images obtained 7 weeks antemortem through the location of the RAP lesion ( Figure 3A ) revealed a highly reflective lesion located in the outer neurosensory retina. This lesion was consistently seen in all antemortem spectral domain OCTs through this area, up to 2 years before death ( Figure 3B ). This feature was also noted in OCT obtained at 1 year and 5 months before the patient's death.
Discussion
Intravitreal ranibizumab injections have been found to be effective in improving visual acuity and reducing OCT macular thickness in patients with RAP lesions. 1, 5, 11, 13 Based on this case, we confirm that RAP lesions appear as highly reflective lesions on OCT. In addition, we show that treatment with serial ranibizumab was associated with an RAP lesion with decreased cellularity as compared with previously published lesions. 14, 15 In our patient, treatment with ranibizumab failed to eliminate the RAP lesion completely. Given the thick-walled fibrotic appearance of the regressed lesion, it seems unlikely that the lesion (arrow) appears as a hypocellular, thick-walled vascular complex abutting the inner portion of Bruch membrane, which has artifactitiously separated from the outer Bruch membrane. As the lesion is followed inferiorly, moving closer to the fovea, the RAP lesion branches and is found in the more superficial layers of the retina, finally terminating in the inner plexiform layer (D). There is a third layer of fibrous tissue immediately below the retinal pigment epithelium, but no neovascular tissue was identified (hematoxylin and eosin, original magnification ·10 before reduction).
could completely disappear. A published report of tomographic evidence of an RAP lesion disappearing after bevacizumab may reflect an earlier stage and less developed RAP lesion, or possibly a small difference in segmentation on subsequent scans. 6 Another consideration is that our patient was treated with antivascular endothelial growth factor therapy alone, so it is unclear whether or not combination of photodynamic therapy with ranibizumab would have led to a difference in the histologic structure of the RAP lesion. 16, 17 The origin of retinal neovascularization in RAP lesions remains a subject of debate. In 2001, Yannuzzi et al 3 suggested that RAP develops first in the retina and then may progress to involve the choroid through retinal-choroidal anastomoses. In 2003, Gass et al 18 suggested an alternative hypothesis that RAP begins first with occult Type 1 neovascularization. Yannuzzi and Freund later revised their classification to include this possibility. 1,2 Optical coherence tomography studies have supported both theories. 6, 7 Unlike our prior reported cases, 14, 15 this case had a thin band of fibrous tissue underlying the RAP lesion deep to the retinal pigment epithelium which may represent a regressed occult choroidal neovascularization membrane. However, there were no anastomoses seen between this tissue and the RAP lesion on serial histopathologic sections. Both the choroid and the retinal circulation remain possible sources for the origin of RAP lesions, but the location of the RAP lesions overlying an intact inner portion of Bruch membrane favors an origin from the retinal circulation. In this case, as in our previous cases, fluorescein angiography demonstrated that there was a pigment epithelial detachment in association with the RAP lesion. This pigment epithelial detachment had resolved during the course of therapy with ranibizumab. The contact of the RAP lesion with the inner portion of Bruch membrane, an area devoid of retinal pigment epithelium, suggests that leakage of fluid from the vascular complex could contribute to the formation of a pigment epithelial detachment as was present in the angiogram of this patient several years before.
Key words: age-related macular degeneration, anti-VEGF, choroidal neovascularization, retinal neovascularization, clinicopathologic correlation, ranibizumab, retinal angiomatous proliferation. Fig. 3 . Appearance of RAP lesion on spectral domain optical coherence tomography examination 7 weeks antemortem (A) and 2 years antemortem (B) as well as histopathology (C). The tomographic appearance of the lesion is a highly reflective lesion located in the outer neurosensory retina (arrows). The corresponding histopathologic appearance of the RAP lesion (C, arrow) is that of a vascular complex in the outer neurosensory retina.
